Could a stool sample replace a spinal tap? new study tests Non-Invasive infection detection

NCT ID NCT07603453

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether analyzing stool and urine samples using a technique called metagenomics can find infections in people with weakened immune systems (due to HIV, chemotherapy, or immunosuppressive drugs). Currently, doctors often need to take invasive samples like blood, spinal fluid, or tissue biopsies to find the cause of an infection. If stool and urine work as well, it could make diagnosis easier and safer. The study will enroll 120 participants and compare results from non-invasive samples with those from standard invasive tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Metagenomic sequencing (mNGS) of stool and urine samples
What this could lead to
If successful, this could allow doctors to diagnose infections in immunocompromised patients using simple stool or urine samples instead of invasive procedures like spinal taps or tissue biopsies.
What could go wrong
This is an early-stage study with only 120 participants, so results may not apply to all patients. The technique may not detect all pathogens, and false positives or negatives are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Necker - Enfants Malades

    Paris, Île-de-France Region, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.